| Delumeau JC, Ikegawa C, Yokoyama C, et al.
An observational study of sucrose-formulated recombinant factor VIII for Japanese patients with haemophilia A. [Journal Article]
Thromb Haemost 2008 Jul; 100(1):32-7.
Abstract | Full Citation |
| Frampton JE, Wagstaff AJ
Sucrose-Formulated Octocog Alfa: A Review of its Use in Patients with Haemophilia A. [JOURNAL ARTICLE]
Drugs 2008; 68(6):839-853.
Abstract | Full Citation | Find Related Articles |
| Musso R, Santagostino E, Faradji A, et al.
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting. [JOURNAL ARTICLE]
Thromb Haemost 2008; 99(1):52-58.
Abstract | Full Citation | Find Related Articles |
| Rubinger M, Lillicrap D, Rivard GE, et al.
A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose. [JOURNAL ARTICLE]
Haemophilia 2008 Jan 8.
Abstract | Full Citation | Find Related Articles |
| Powell JS
Liposomal approach towards the development of a longer-acting factor VIII. [Journal Article]
Haemophilia 2007 Sep.:23-8.
Abstract | Full Citation | Find Related Articles |
| Shi J, Zhao Y, Wu J, et al.
Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China. [Journal Article]
Haemophilia 2007 Jul; 13(4):351-6.
Abstract | Full Citation | Find Related Articles |
| Josephson CD, Abshire T
The New Albumin-Free Recombinant Factor VIII Concentrates for Treatment of Hemophilia: Do They Represent an Actual Incremental Improvement? [Journal Article]
Clin Adv Hematol Oncol 2004 Jul; 2(7):441-6.
Abstract | Full Citation | Find Related Articles |
| Kreuz W, Gill JC, Rothschild C, et al.
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation. [Clinical Trial, Phase III, Journal Article, Multicenter Study]
Thromb Haemost 2005 Mar; 93(3):457-67.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Takedani H, Abe Y, Kajiwara M, et al.
[Intravenous catheter occlusion during continuous infusion of a new recombinant factor VIII concentrate] [Case Reports, Journal Article]
Rinsho Ketsueki 2003 May; 44(5):339-41.
Abstract | Full Citation | Find Related Articles |
| Suiter TM
First and next generation native rFVIII in the treatment of hemophilia A. What has been achieved? Can patients be switched safely? [Journal Article, Review]
Semin Thromb Hemost 2002 Jun; 28(3):277-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
